Preview

Systemic Hypertension

Advanced search

Knowledge of senior students in the definition, classification, and approaches to the treatment of arterial hypertension. Final results of the PHYSTARH project

https://doi.org/10.26442/2075082X.2021.4.200897

Abstract

Background. Arterial hypertension is a modifiable risk factor for the development of life-threatening cardiovascular complications. Early diagnosis and optimal treatment are the key to success in the fight against this pathology. Aim. To analyze the knowledge of senior medical students from different regions in the basic issues of hypertension. Materials and methods. The article presents the results of the first stage of the multicenter PHYSTARH study (the full name of the project is Physicians’ and undergraduates’ knowledge in arterial hypertension treatment). An anonymous questionnaire (pharmacoepidemiological survey) was conducted among 314 senior medical students from 6 cities of Russia and Ukraine. Results. The study revealed the average level of senior students’ knowledge. The average level of correct answers to the questions in the first part of the questionnaire was 49.4%. The minimum level of correct answers was obtained in the questions of determining hypertension by the value of home blood pressure monitoring, determining the degree of hypertension for a blood pressure of 140/110 mm Hg, the incidence of resistant hypertension, indications for drug correction of high normal blood pressure, the choice of the optimal class of drugs for initial antihypertensive therapy. The maximum level of correct answers was registered only for the question about the definition of hypertension. Conclusion. The results of the study indicate an insufficiently high level of students’ basic knowledge in the classification and treatment of hypertension.

About the Authors

R. A. Bontsevich
Belgorod State National Research University; Medical center “Azbuka zdorovya”
Russian Federation


Y. R. Vovk
Kursk State Medical University; Medical center “ST-Clinic”
Russian Federation


A. A. Gavrilova
Belgorod State National Research University
Russian Federation


G. A. Batishcheva
Burdenko Voronezh State Medical University
Russian Federation


N. Iu. Goncharova
Burdenko Voronezh State Medical University
Russian Federation


I. O. Elizarova
Burdenko Voronezh State Medical University
Russian Federation


G. G. Ketova
South Ural State Medical University
Russian Federation


V. O. Barysheva
Endocrinology Research Centre
Russian Federation


G. M. Bikkinina
Bashkir State Medical University
Russian Federation


O. V. Myronenko
Dnipro State Medical University
Russian Federation


References

1. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. 2017;389(10064):37-55. DOI:10.1016/S0140-6736(16)31919-5

2. Ford ES, Ajani UA, Groft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007;356(23):2388-98. DOI:10.1056/NEJMsa053935

3. Lawes CMM, Vander Hoorn S, Rodgers A; International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371(9623):1513-8. DOI:10.1016/S0140-6736(08)60655-8

4. Oliveros E, Patel H, Kyung S, et al. Hypertension in older adults: Assessment, management, and challenges. Clin Cardiol. 2020;43(2):99-107. DOI:10.1002/clc.23303

5. Бойцов С.А., Баланова Ю.А., Шальнова С.А., и др. Артериальная гипертония среди лиц 25-64 лет: распространенность, осведомленность, лечение и контроль. По материалам исследования ЭССЕ. Кардиоваскулярная терапия и профилактика. 2014;13(4):4-14 DOI:10.15829/1728-8800-2014-4-4-14

6. Bontsevich R, Chernykh A, Leonova A, et al. Physicians’ and undergraduates’ knowledge of drugs contraindicated for arterial hypertension treatment. Eur J Clin Pharmacol. 2019;75(Suppl. 1):S28(EACPT- 1241). The Abstracts: 14th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT). 29 June - 2 July 2019, Stockholm, Sweden. DOI:10.1007/s00228-019-02685-2

7. Bontsevich RA, Vovk YaR, Gavrilova AA, et al. Physicians’ and senior medical students’ knowledge of drugs contraindicated for arterial hypertension treatment according to the PHYSTARH study. Sys Rev Pharm. 2020;11(6):26-30. DOI:10.31838/srp.2020.6.06

8. Бонцевич Р.А., Вовк Я.Р., Гаврилова А.А., и др. Этиопатогенез, диагностика и подходы к лечению артериальной гипертонии: оценка базовых знаний врачей терапевтического профиля. Финальные результаты проекта PHYSTARH. Системные гипертензии. 2021;18(1):25-30 DOI:10.26442/2075082X.2021.1.200346

9. Бонцевич Р.А., Вовк Я.Р., Гаврилова А.А., и др. Медикаментозная терапия артериальной гипертонии: оценка базовых знаний врачей терапевтического профиля. Финальные результаты проекта PHYSTARH. Системные гипертензии. 2021;18(2):80-7 DOI:10.26442/2075082X.2021.2.200884

10. Mancia G, Fagard R, Narkiewicz K, et al.; Task Force Members. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281-357. DOI:10.1097/01.hjh.0000431740.32696.cc

11. Кобалава Ж.Д., Конради А.О., Недогода С.В., и др. Артериальная гипертензия у взрослых. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;25(3):3786 DOI:10.15829/1560-4071-2020-3-3786

12. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-104. DOI:10.1093/eurheartj/ehy339

13. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269-324. DOI:10.1161/HYP.0000000000000066

14. Carey RM, Calhoun DA, Bakris GL, et al. Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association. Hypertension. 2018;72(5):e53-90. DOI:10.1161/HYP.0000000000000084

15. Noubiap JJ, Nansseu JR, Nyaga UF, et al. Global prevalence of resistant hypertension: a meta-analysis of data from 3.2 million patients. Heart. 2019;105(2):98-105. DOI:10.1136/heartjnl-2018-313599

16. Nuredini G, Saunders A, Rajkumar C, Okorie M. Current status of white coat hypertension: where are we? Ther Adv Cardiovasc Dis. 2020;14:1753944720931637. DOI:10.1177/1753944720931637

17. Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension. 2002;40(6):795-6. DOI:10.1161/01.hyp.0000038733.08436.98

18. Чазова И.Е., Жернакова Ю.В. от имени экспертов. Клинические рекомендации. Диагностика и лечение артериальной гипертонии. Системные гипертензии. 2019;16(1):6-31 DOI:10.26442/2075082X.2019.1.190179

19. Thomopoulos C, Parati G, Zanchetti A. Effects of blood-pressure-lowering treatment on outcome incidence. 12. Effects in individuals with high-normal and normal blood pressure: overview and meta-analyses of randomized trials. J Hypertens. 2017;35(11):2150-60. DOI:10.1097/HJH.0000000000001547


Review

For citations:


Bontsevich R.A., Vovk Y.R., Gavrilova A.A., Batishcheva G.A., Goncharova N.I., Elizarova I.O., Ketova G.G., Barysheva V.O., Bikkinina G.M., Myronenko O.V. Knowledge of senior students in the definition, classification, and approaches to the treatment of arterial hypertension. Final results of the PHYSTARH project. Systemic Hypertension. 2021;18(4):169-174. (In Russ.) https://doi.org/10.26442/2075082X.2021.4.200897

Views: 107


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2075-082X (Print)
ISSN 2542-2189 (Online)